Last update 01 Nov 2024
P4HB x STING
Last update 01 Nov 2024
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
一项评估TSN222对晚期实体瘤或淋巴瘤受试者的安全性、耐受性、药代动力学及初步疗效评估的I/II期临床研究
[Translation] A Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of TSN222 in subjects with advanced solid tumors or lymphomas
A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of TSN222 in Subjects With Advanced Solid Tumors or Lymphoma
100 Clinical Results associated with P4HB x STING
Login to view more data
100 Translational Medicine associated with P4HB x STING
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free